Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neuropathol Exp Neurol

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    November 2022
  1. NORRIS GA, Willard N, Donson AM, Gaskell A, et al
    PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem.
    J Neuropathol Exp Neurol. 2022 Nov 28:nlac112. doi: 10.1093.
    PubMed    


  2. OULD ISMAIL AA, Parra O, Hughes EG, Green DC, et al
    Novel FGFR2::ZCCHC24 Fusion in Dysembryoplastic Neuroepithelial Tumor.
    J Neuropathol Exp Neurol. 2022;81:1029-1032.
    PubMed    


  3. VIZCAINO MA, Giannini C, King RL, Johnson DR, et al
    Primary Leptomeningeal Lymphoma: Clinicopathologic Features of 2 Rare Phenotypes.
    J Neuropathol Exp Neurol. 2022;81:1002-1007.
    PubMed     Abstract available


  4. RAGHUNATHAN A, Ida CM, Westbroek EM, Gupta S, et al
    Mutations of FH and IDH may induce gliomagenesis by similar mechanisms.
    J Neuropathol Exp Neurol. 2022 Nov 11. pii: 6823866. doi: 10.1093.
    PubMed    


  5. TREJO-LOPEZ JA, Praska CE, Zepeda Mendoza C, Kollmeyer TM, et al
    H3 G34 mutation assessment for diffuse gliomas in adults: when would testing be most diagnostically useful?
    J Neuropathol Exp Neurol. 2022 Nov 3. pii: 6795064. doi: 10.1093.
    PubMed    


    October 2022
  6. AHRENDSEN JT, Freund RS, Hsu N, Bryke C, et al
    Cytogenetic and Molecular Characterization of IDH-Wildtype Glioblastomas and Grade 4 IDH-Mutant Astrocytomas with Unusual Histology.
    J Neuropathol Exp Neurol. 2022 Oct 18. pii: 6762949. doi: 10.1093.
    PubMed     Abstract available


  7. LEROND J, Morisse MC, Letourneur Q, Gimonnet C, et al
    Immune Microenvironment and Lineage Tracing Help to Decipher Rosette-Forming Glioneuronal Tumors: A Multi-Omics Analysis.
    J Neuropathol Exp Neurol. 2022;81:873-884.
    PubMed     Abstract available


  8. SHIVELY SB, Edwards NA, MacDonald TJ, Johnson KR, et al
    Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.
    J Neuropathol Exp Neurol. 2022;81:885-899.
    PubMed     Abstract available


    September 2022
  9. TUBRE T, Hacking S, Alexander A, Brickman A, et al
    Prostate-Specific Membrane Antigen Expression in Meningioma: A Promising Theranostic Target.
    J Neuropathol Exp Neurol. 2022 Sep 30. pii: 6732413. doi: 10.1093.
    PubMed     Abstract available


  10. HEIN AL, Cathcart SJ, Cushman-Vokoun A, Shonka NA, et al
    EGFR Exon 20 Insertion in Bithalamic and Unithalamic Glioma: A Report of 2 Cases and Literature Review.
    J Neuropathol Exp Neurol. 2022 Sep 12. pii: 6696214. doi: 10.1093.
    PubMed    


    August 2022
  11. BERRY JF, Vidrine DW, Wojcik AA, Trivedi D, et al
    Glioblastoma, IDH-Wildtype Harboring a KIAA1549::BRAF Fusion: Report of a Case With Comprehensive Molecular Profiling.
    J Neuropathol Exp Neurol. 2022 Aug 27. pii: 6678072. doi: 10.1093.
    PubMed    


  12. GARCIA MR, Feng Y, Vasudevaraja V, Galbraith K, et al
    Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas.
    J Neuropathol Exp Neurol. 2022 Aug 23. pii: 6673886. doi: 10.1093.
    PubMed     Abstract available


  13. LEELATIAN N, Goss J, Pastakia D, Dewan MC, et al
    Primary Intracranial Sarcoma, DICER1-Mutant Presenting as a Pineal Region Tumor Mimicking Pineoblastoma: Case Report and Review of the Literature.
    J Neuropathol Exp Neurol. 2022;81:762-764.
    PubMed    



  14. Correction to: Basal Recess in Third Ventricle Tumors: A Pathological Feature Defining a Clinical-Topographical Subpopulation of Papillary Craniopharyngiomas.
    J Neuropathol Exp Neurol. 2022 Aug 13. pii: 6665892. doi: 10.1093.
    PubMed    


    July 2022
  15. MO H, Magaki S, Deisch JK, Raghavan R, et al
    Isocitrate Dehydrogenase Mutations Are Associated with Different Expression and DNA Methylation Patterns of OLIG2 in Adult Gliomas.
    J Neuropathol Exp Neurol. 2022 Jul 20. pii: 6647005. doi: 10.1093.
    PubMed     Abstract available


  16. LUCAS CG, Davidson CJ, Alashari M, Putnam AR, et al
    Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.
    J Neuropathol Exp Neurol. 2022;81:650-657.
    PubMed     Abstract available


    June 2022

  17. Correction to: Tumor-Derived Cell Culture Model for the Investigation of Meningioma Biology.
    J Neuropathol Exp Neurol. 2022 Jun 17. pii: 6613581. doi: 10.1093.
    PubMed    


    May 2022
  18. LIU C, Chen X, Zhang L, Liu J, et al
    F-Box Protein 11 Suppresses Cell Proliferation and Aerobic Glycolysis in Glioblastomas by Mediating the Ubiquitin Degradation of Cdc25A.
    J Neuropathol Exp Neurol. 2022 May 18. pii: 6587358. doi: 10.1093.
    PubMed     Abstract available


  19. TUNA G, Dal-Bekar NE, Akay A, Ruksen M, et al
    Minimally Invasive Detection of IDH1 Mutation With Cell-Free Circulating Tumor DNA and D-2-Hydroxyglutarate, D/L-2-Hydroxyglutarate Ratio in Gliomas.
    J Neuropathol Exp Neurol. 2022 May 18. pii: 6587360. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  20. PASCUAL JM, Prieto R, Carrasco R, Barrios L, et al
    Basal Recess in Third Ventricle Tumors: A Pathological Feature Defining a Clinical-Topographical Subpopulation of Papillary Craniopharyngiomas.
    J Neuropathol Exp Neurol. 2022 Apr 26. pii: 6574454. doi: 10.1093.
    PubMed     Abstract available


  21. SAHU U, Barth RF, Otani Y, McCormack R, et al
    Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.
    J Neuropathol Exp Neurol. 2022 Apr 21. pii: 6572007. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  22. TROY C, Gill BJA, Miller ML, Hickman RA, et al
    Adenocarcinoma Arising in a Yolk Sac Tumor of the Pineal Gland.
    J Neuropathol Exp Neurol. 2022;81:291-295.
    PubMed    


  23. VALERIO E, Alves de Castro JV, Carraro DM, Torrezan GT, et al
    Beyond Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with Aggressive Behavior.
    J Neuropathol Exp Neurol. 2022 Mar 18. pii: 6550548. doi: 10.1093.
    PubMed    


    February 2022
  24. TOGNI C, Rom E, Burghardt I, Roth P, et al
    Prognostic Relevance of Transforming Growth Factor-beta Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype.
    J Neuropathol Exp Neurol. 2022;81:225-235.
    PubMed     Abstract available


    January 2022
  25. BITAR M, Chornenkyy Y, Flanagan ME, Steffens A, et al
    The Frequency of Focal Cortical Dysplasia-Like Histologic Features Near Adult-Type Diffuse Gliomas.
    J Neuropathol Exp Neurol. 2022;81:48-53.
    PubMed     Abstract available


  26. ABOUBAKR O, Metais A, Berthaud C, Gigant P, et al
    L1CAM Is Not a Reliable Diagnostic Biomarker for Distinguishing Supratentorial Ependymomas, ZFTA Fusion-Positive From Other Central Nervous System Tumors.
    J Neuropathol Exp Neurol. 2022;81:82-85.
    PubMed    


  27. ONYENEKWU CP, Cunningham AM, Schilter K, Reddi HV, et al
    Diffuse Leptomeningeal Histiocytic Sarcoma: Histologic and Molecular Findings in an Autopsy Case.
    J Neuropathol Exp Neurol. 2022;81:79-81.
    PubMed    


  28. VIZCAINO MA, Kurtin PJ, King RL, Spinner RJ, et al
    Diffuse Large B-Cell Lymphoma of Peripheral Nerve with Distinctive Pathological Features Resembling Primary CNS Lymphoma.
    J Neuropathol Exp Neurol. 2022;81:76-78.
    PubMed    


    December 2021
  29. KRONISH A, DeNardo B, Kanach C, Lulla RR, et al
    Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma.
    J Neuropathol Exp Neurol. 2021;80:1141-1142.
    PubMed    


  30. KIMURA T, Ikedo T, Ohta-Ogo K, Hamano E, et al
    A Pathologically Verified Case of Peripheral Intracranial Aneurysmal Formation With Massively Infiltrating Meningioma Cells.
    J Neuropathol Exp Neurol. 2021 Dec 29. pii: 6487232. doi: 10.1093.
    PubMed    


  31. SASAKI S, Takeda M, Hirose T, Fujii T, et al
    Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.
    J Neuropathol Exp Neurol. 2021 Dec 13. pii: 6460154. doi: 10.1093.
    PubMed     Abstract available


  32. ROSAGER AM, Dahlrot RH, Sorensen MD, Bangso JA, et al
    The Epigenetic Regulator Jumonji Domain-Containing Protein 6 (JMJD6) Is Highly Expressed but Not Prognostic in IDH-Wildtype Glioblastoma Patients.
    J Neuropathol Exp Neurol. 2021 Dec 7. pii: 6454863. doi: 10.1093.
    PubMed     Abstract available


  33. LARKIN CJ, Jennings LJ, Heimberger AB, Horbinski C, et al
    Next-Generation Sequencing of a Glioblastoma with True Epithelial Differentiation.
    J Neuropathol Exp Neurol. 2021 Dec 3. pii: 6448594. doi: 10.1093.
    PubMed    


    November 2021
  34. UHLMANN EJ, Rabinovsky R, Varma H, El Fatimy R, et al
    Tumor-Derived Cell Culture Model for the Investigation of Meningioma Biology.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445140. doi: 10.1093.
    PubMed     Abstract available


  35. LIND KT, Chatwin HV, DeSisto J, Coleman P, et al
    Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445141. doi: 10.1093.
    PubMed     Abstract available


  36. CHKHEIDZE R, Raisanen J, Gagan J, Richardson TE, et al
    Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445139. doi: 10.1093.
    PubMed     Abstract available


  37. KLEINSCHMIDT-DEMASTERS BK
    Metastases to the Pituitary Gland: Histological Patterns of Spread and Review of the Literature.
    J Neuropathol Exp Neurol. 2021;80:1033-1042.
    PubMed     Abstract available


    October 2021
  38. OON ML, Low SYY, Kuick CH, Goh JY, et al
    An Unusual Ganglioglioma with Pseudopapillary Features and PRKAR2B-BRAF Fusion.
    J Neuropathol Exp Neurol. 2021;80:1000-1003.
    PubMed    


  39. LIN CC, Mansukhani MM, Bruce JN, Canoll P, et al
    Rosette-Forming Glioneuronal Tumor in the Pineal Region: A Series of 6 Cases and Literature Review.
    J Neuropathol Exp Neurol. 2021;80:933-943.
    PubMed     Abstract available


  40. AHN JS, Ervin J, Cummings TJ, Lopez GY, et al
    Papillary Glioneuronal Tumor With a Novel GPR37L1-PRKCA Fusion.
    J Neuropathol Exp Neurol. 2021;80:1004-1006.
    PubMed    


    September 2021
  41. AHRENDSEN JT, Sinai C, Meredith DM, Malinowski SW, et al
    Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
    J Neuropathol Exp Neurol. 2021 Sep 27. pii: 6377085. doi: 10.1093.
    PubMed     Abstract available


  42. KARPATHIOU G, Ferrand E, Camy F, Babiuc SM, et al
    Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas.
    J Neuropathol Exp Neurol. 2021;80:830-834.
    PubMed     Abstract available


  43. LIN CC, Lefferts JA, Chan AM, Zanazzi G, et al
    Rare Activating BRAF Alteration Involving the beta3-alphaC Kinase Domain in Ganglioglioma.
    J Neuropathol Exp Neurol. 2021;80:887-889.
    PubMed    


  44. DONO A, Pothiawala AZ, Lewis CT, Bhattacharjee MB, et al
    Molecular Alterations in Meningioangiomatosis Causing Epilepsy.
    J Neuropathol Exp Neurol. 2021 Sep 27. pii: 6377086. doi: 10.1093.
    PubMed     Abstract available


  45. SMITH HL, Collins J, Park D, Darlington W, et al
    Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants.
    J Neuropathol Exp Neurol. 2021 Sep 15. pii: 6370674. doi: 10.1093.
    PubMed    


  46. CHEN J, Lee H, Schmitt P, Choy CJ, et al
    Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.
    J Neuropathol Exp Neurol. 2021 Sep 15. pii: 6370675. doi: 10.1093.
    PubMed     Abstract available


  47. SUGITA Y, Hashimoto G, Fukuda K, Takahashi K, et al
    Primary Nondural Central Nervous System Marginal ZoneB-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type Mimicking CNS Inflammatory Diseases.
    J Neuropathol Exp Neurol. 2021;80:789-799.
    PubMed     Abstract available


  48. AHANGARI N, Munoz DG, Coulombe J, Gray DA, et al
    Nuclear IMPDH Filaments in Human Gliomas.
    J Neuropathol Exp Neurol. 2021 Sep 8. pii: 6366485. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  49. MOVAHED-EZAZI M, Skalina KA, Parashar K, Manjila S, et al
    A Rare Presentation of Low-Grade Prostate Adenocarcinoma as Delayed Pineal Region Metastasis: A Case Report and Review of Multicenter Clinical Experience in Prostate Carcinoma Brain Metastases.
    J Neuropathol Exp Neurol. 2021 Aug 13. pii: 6350804. doi: 10.1093.
    PubMed    


  50. LEBRUN L, Bizet M, Melendez B, Alexiou B, et al
    Analyses of DNA Methylation Profiling in the Diagnosis of Intramedullary Astrocytomas.
    J Neuropathol Exp Neurol. 2021;80:663-673.
    PubMed     Abstract available


  51. COVELLI C, Parente P, Icolaro N, Dimitri LMC, et al
    Primary Epithelioid Hemangioma of the Central Nervous System: A Case Report and Review of the Literature.
    J Neuropathol Exp Neurol. 2021;80:717-719.
    PubMed    


    July 2021
  52. FOIANI G, Guelfi G, Mandara MT
    MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
    J Neuropathol Exp Neurol. 2021 Jul 17. pii: 6323287. doi: 10.1093.
    PubMed     Abstract available


  53. PROSNIAK M, Kenyon LC, Hooper DC
    Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
    J Neuropathol Exp Neurol. 2021 Jul 16. pii: 6322918. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  54. LUCAS CG, Devine P, Solomon DA, Giannini C, et al
    Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
    J Neuropathol Exp Neurol. 2021 Jun 12. pii: 6297520. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  55. KNUDSEN AM, Rudkjobing SJ, Sorensen MD, Dahlrot RH, et al
    Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276054. doi: 10.1093.
    PubMed     Abstract available


  56. HIRAKI T, Fukuoka K, Mori M, Arakawa Y, et al
    Application of Genome-Wide DNA Methylation Analysis to Differentiate a Case of Radiation-Induced Glioblastoma From Late-Relapsed Medulloblastoma.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276056. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  57. GOSCHZIK T, Zur Muehlen A, Doerner E, Waha A, et al
    Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
    J Neuropathol Exp Neurol. 2021;80:419-430.
    PubMed     Abstract available


  58. STEPHEN NIX J, Ida CM
    What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors.
    J Neuropathol Exp Neurol. 2021 Apr 9. pii: 6219399. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  59. DAHL NA, Donson AM, Sanford B, Wang D, et al
    NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.
    J Neuropathol Exp Neurol. 2021 Mar 22. pii: 6179633. doi: 10.1093.
    PubMed     Abstract available


  60. RICHARDSON TE, Sathe AA, Xing C, Mirchia K, et al
    Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.
    J Neuropathol Exp Neurol. 2021;80:354-365.
    PubMed     Abstract available


  61. ULLOA-NAVAS MJ, Rubio L, Teruel-Sanchis A, Pena-Pena J, et al
    Heterogeneous Pattern of Differentiation With BCAS1/NABC1 Expression in a Case of Oligodendroglioma.
    J Neuropathol Exp Neurol. 2021;80:379-383.
    PubMed    


  62. PHAM K, Maxwell MJ, Sweeney H, Alt J, et al
    Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
    J Neuropathol Exp Neurol. 2021 Mar 13. pii: 6169464. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  63. SMITH MJ, Pathmanaban ON, Coope DJ, King AT, et al
    Comment on: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:289-290.
    PubMed    


  64. FONKEM E, Peng S, Berens M, Mukherjee S, et al
    Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:290-291.
    PubMed    


  65. MIYAKE Y, Fujii K, Nakamaura T, Ikegaya N, et al
    IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.
    J Neuropathol Exp Neurol. 2021;80:247-253.
    PubMed     Abstract available


  66. DAOUD EV, Patel A, Gagan J, Raisanen JM, et al
    Spinal Cord Pilocytic Astrocytoma With FGFR1-TACC1 Fusion and Anaplastic Transformation.
    J Neuropathol Exp Neurol. 2021;80:283-285.
    PubMed    


  67. PRYZBYLSKI AL, Kollmeyer TM, Praska CE, Raghunathan A, et al
    Non-canonical IDH Mutation Frequency in IDH1-R132H-Negative Glioblastoma Patients Older Than 54 Years.
    J Neuropathol Exp Neurol. 2021 Feb 7. pii: 6130116. doi: 10.1093.
    PubMed    


  68. HEALY E
    Corrigendum to: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021 Feb 4. pii: 6127560. doi: 10.1093.
    PubMed    


    January 2021
  69. MOVAHED-EZAZI M, Schwartz PJ, Zimmerman DL, Song X, et al
    Subependymal Giant Cell Astrocytoma in a 79-Year-Old Woman without Clinical Features of Tuberous Sclerosis: A Case Report.
    J Neuropathol Exp Neurol. 2021;80:199-201.
    PubMed    


  70. YEUNG J, Yaghoobi V, Aung TN, Vesely MD, et al
    Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.
    J Neuropathol Exp Neurol. 2021 Jan 4. pii: 6061497. doi: 10.1093.
    PubMed     Abstract available


  71. HOLSTEN T, Lubieniecki F, Spohn M, Mynarek M, et al
    Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas.
    J Neuropathol Exp Neurol. 2021;80:52-59.
    PubMed     Abstract available


  72. BARRESI V, Simbolo M, Gessi M, Rossi S, et al
    Clinical-Pathological, Immunohistochemical, and Genetic Characterization of a Series of Posterior Pituitary Tumors.
    J Neuropathol Exp Neurol. 2021;80:45-51.
    PubMed     Abstract available


  73. ARCHILLA I, Guerrero J, Reyes Figueroa LA, Capurro S, et al
    Intra-Axial Frontal Cyst with Ependymoma-Like Proliferation: Neuroectodermal or Neurenteric?
    J Neuropathol Exp Neurol. 2021;80:93-95.
    PubMed    


    December 2020
  74. WANG YH, Huang TL, Chen X, Yu SX, et al
    Glioma-Derived TSP2 Promotes Excitatory Synapse Formation and Results in Hyperexcitability in the Peritumoral Cortex of Glioma.
    J Neuropathol Exp Neurol. 2020 Dec 31. pii: 6056628. doi: 10.1093.
    PubMed     Abstract available


  75. MITANI Y, Fukuoka K, Mori M, Arakawa Y, et al
    Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
    J Neuropathol Exp Neurol. 2020 Dec 25. pii: 6047589. doi: 10.1093.
    PubMed    


  76. GOODMAN AL, Velazquez Vega JE, Rey Martinez LC, Brat DJ, et al
    Epithelioid Pituicytoma: Expanding the Morphologic Spectrum of a Rare Neoplasm.
    J Neuropathol Exp Neurol. 2020;79:1376-1378.
    PubMed    


    November 2020
  77. NATSUMEDA M, Miyahara H, Yoshimura J, Nakata S, et al
    GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma.
    J Neuropathol Exp Neurol. 2020 Nov 29. pii: 6010620. doi: 10.1093.
    PubMed     Abstract available


  78. ALSAFWANI N, Alrjoub M, Djuric U, Gao A, et al
    Tumor-Infiltrating Lymphocytes Are Enriched in Nonhypoxic Glioblastoma Niches.
    J Neuropathol Exp Neurol. 2020 Nov 19. pii: 5992386. doi: 10.1093.
    PubMed    


  79. YAO K, Duan Z, Du Z, Fan X, et al
    PRKCA D463H Mutation in Chordoid Glioma of the Third Ventricle: A Cohort of 16 Cases, Including Two Cases Harboring BRAFV600E Mutation.
    J Neuropathol Exp Neurol. 2020;79:1183-1192.
    PubMed     Abstract available


  80. NAVALKELE P, Guzman M, Kirby A, Pinz H, et al
    Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.
    J Neuropathol Exp Neurol. 2020;79:1250-1252.
    PubMed    


  81. GILBERT AR, Yan L, McDougall CM
    Broadening the Age of Incidence of Intracranial Angiomatoid Fibrous Histiocytoma With EWSR1-CREM Fusion: A Case Report.
    J Neuropathol Exp Neurol. 2020;79:1244-1246.
    PubMed    


  82. SAN-MIGUEL T, Navarro L, Sanchez-Sendra B, Megias J, et al
    Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation.
    J Neuropathol Exp Neurol. 2020;79:1233-1238.
    PubMed     Abstract available


  83. ZHENG H, Baranova K, Song J, Yan L, et al
    Overexpression of Long Noncoding RNA HOTAIR Is a Unique Epigenetic Characteristic of Myxopapillary Ependymoma.
    J Neuropathol Exp Neurol. 2020;79:1193-1202.
    PubMed     Abstract available


    October 2020
  84. SALLE H, Durand K, Gantois C, Labrousse F, et al
    Myxoid Meningioma: First Report of a Rare Metaplastic Meningioma Variant in the Pineal Region.
    J Neuropathol Exp Neurol. 2020 Oct 17. pii: 5928920. doi: 10.1093.
    PubMed    


  85. GITTO L, Serinelli S, Galbraith K, Williams M, et al
    Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
    J Neuropathol Exp Neurol. 2020;79:1044-1053.
    PubMed     Abstract available


    September 2020
  86. DAL COL P, Poncet D, Rivoirard R, Vassal F, et al
    Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression.
    J Neuropathol Exp Neurol. 2020;79:1011-1014.
    PubMed     Abstract available


    August 2020
  87. ZANAZZI G, Pendrick D, Lin CC, Higgins D, et al
    Pineal Region High-Grade Glioneuronal Tumor With a Novel ZBTB10-NTRK3 Fusion.
    J Neuropathol Exp Neurol. 2020;79:929-931.
    PubMed    


  88. TANG K, Kurland D, Vasudevaraja V, Serrano J, et al
    Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
    J Neuropathol Exp Neurol. 2020;79:880-890.
    PubMed     Abstract available


    July 2020
  89. MORISAKO T, Shishido-Hara Y, Inaba T, Takeuchi H, et al
    Primary CNS CD45-Depleted T-Cell Lymphoma: The First Pathologically Confirmed Case.
    J Neuropathol Exp Neurol. 2020;79:817-820.
    PubMed    


  90. SHAHAB S, Rubens J, Kaur H, Sweeney H, et al
    MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
    J Neuropathol Exp Neurol. 2020;79:746-753.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: